Federal Register Notice: FDA’s Gastrointestinal Drugs Advisory Committee will meet 7/21, from 8 a.m. to 4 p.m. at the Hilton Washington DC/Silver Spring, The Ballrooms, 8727 Colesville Rd., Silver Spring, MD. The committee will discuss the results from a clinical trial of a Centocor Ortho Biotech supplement biologics license application for Remicade (infliximab) in treating pediatric patients with moderately to severely active ulcerative colitis. Contact Kristine T. Khuc, (301) 796-9001. To view this notice, click here.